Literature DB >> 17440079

Transforming growth factor beta signaling via Ras in mesenchymal cells requires p21-activated kinase 2 for extracellular signal-regulated kinase-dependent transcriptional responses.

Kaori Suzuki1, Mark C Wilkes, Nandor Garamszegi, Maryanne Edens, Edward B Leof.   

Abstract

Transforming growth factor beta (TGF-beta) signaling via Smad proteins occurs in various cell types. However, whereas the biological response to TGF-beta can be as distinct as growth promoting (i.e., mesenchymal cells) versus growth inhibiting (i.e., epithelial cells), few discernible differences in TGF-beta signaling have been reported. In the current study, we examined the role of Ras in the proliferative response to TGF-beta and how it might interface with Smad-dependent and Smad-independent TGF-beta signaling targets. TGF-beta stimulated Ras activity in a subset of mesenchymal, but not epithelial, cultures and was required for extracellular signal-regulated kinase (ERK)-dependent transcriptional responses. Although dominant negative Ras had no effect on TGF-beta internalization or Smad-dependent signaling (i.e., phosphorylation, nuclear translocation, or SBE-luciferase activity), it did prevent the hyperphosphorylation of the Smad transcriptional corepressor TG-interacting factor (TGIF). This was not sufficient, however, to overcome the mitogenic response stimulated by TGF-beta, which was dependent on signals downstream of p21-activated kinase 2 (PAK2). Moreover, although the initial activation of Ras and PAK2 are distinctly regulated, TGF-beta-stimulated PAK2 activity is required for Ras-dependent ERK phosphorylation and Elk-1 transcription. These findings show the requirement for crosstalk between two Smad-independent pathways in regulating TGF-beta proliferation and indicate that the mechanism(s) by which TGF-beta stimulates growth is not simply the opposite of its growth inhibitory actions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17440079     DOI: 10.1158/0008-5472.CAN-06-3211

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  20 in total

1.  Profibrotic up-regulation of glucose transporter 1 by TGF-β involves activation of MEK and mammalian target of rapamycin complex 2 pathways.

Authors:  Mahefatiana Andrianifahanana; Danielle M Hernandez; Xueqian Yin; Jeong-Han Kang; Mi-Yeon Jung; Youli Wang; Eunhee S Yi; Anja C Roden; Andrew H Limper; Edward B Leof
Journal:  FASEB J       Date:  2016-08-01       Impact factor: 5.191

2.  p21-Activated kinase 2 (PAK2) inhibits TGF-β signaling in Madin-Darby canine kidney (MDCK) epithelial cells by interfering with the receptor-Smad interaction.

Authors:  Xiaohua Yan; Junyu Zhang; Qinyu Sun; Polygena T Tuazon; Xiaoping Wu; Jolinda A Traugh; Ye-Guang Chen
Journal:  J Biol Chem       Date:  2012-03-05       Impact factor: 5.157

3.  Delayed administration of suramin attenuates the progression of renal fibrosis in obstructive nephropathy.

Authors:  Na Liu; Evelyn Tolbert; Murugavel Ponnusamy; Haidong Yan; Shougang Zhuang
Journal:  J Pharmacol Exp Ther       Date:  2011-05-27       Impact factor: 4.030

Review 4.  TGFbeta in Cancer.

Authors:  Joan Massagué
Journal:  Cell       Date:  2008-07-25       Impact factor: 41.582

5.  PAI-1 secretion of endometrial and endometriotic cells is Smad2/3- and ERK1/2-dependent and influences cell adhesion.

Authors:  Cong Sui; Ezekiel Mecha; Charles Oa Omwandho; Anna Starzinski-Powitz; Angelika Stammler; Hans-Rudolf Tinneberg; Lutz Konrad
Journal:  Am J Transl Res       Date:  2016-05-15       Impact factor: 4.060

6.  Profibrotic TGFβ responses require the cooperative action of PDGF and ErbB receptor tyrosine kinases.

Authors:  Mahefatiana Andrianifahanana; Mark C Wilkes; Shiv K Gupta; Rod A Rahimi; Claire E Repellin; Maryanne Edens; Joshua Wittenberger; Xueqian Yin; Elizabeth Maidl; Jackson Becker; Edward B Leof
Journal:  FASEB J       Date:  2013-08-02       Impact factor: 5.191

7.  PDGF receptor-α promotes TGF-β signaling in hepatic stellate cells via transcriptional and posttranscriptional regulation of TGF-β receptors.

Authors:  Chunsheng Liu; Jiachu Li; Xiaoyu Xiang; Luyang Guo; Kangsheng Tu; Qinghua Liu; Vijay H Shah; Ningling Kang
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-08-28       Impact factor: 4.052

Review 8.  Schistosoma mansoni: TGF-beta signaling pathways.

Authors:  Philip T Loverde; Ahmed Osman; Andrew Hinck
Journal:  Exp Parasitol       Date:  2007-06-16       Impact factor: 2.011

9.  Distinct roles for mammalian target of rapamycin complexes in the fibroblast response to transforming growth factor-beta.

Authors:  Rod A Rahimi; Mahefatiana Andrianifahanana; Mark C Wilkes; Maryanne Edens; Theodore J Kottom; John Blenis; Edward B Leof
Journal:  Cancer Res       Date:  2009-01-01       Impact factor: 12.701

10.  Enhancer of Zeste Homolog 2 Inhibition Attenuates Renal Fibrosis by Maintaining Smad7 and Phosphatase and Tensin Homolog Expression.

Authors:  Xiaoxu Zhou; Xiujuan Zang; Murugavel Ponnusamy; Monica V Masucci; Evelyn Tolbert; Rujun Gong; Ting C Zhao; Na Liu; George Bayliss; Lance D Dworkin; Shougang Zhuang
Journal:  J Am Soc Nephrol       Date:  2015-12-23       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.